WHO Good Governance for Medicines programme: an innovative approach to prevent corruption in the pharmaceutical sector. Compilation of country case studies and best practices

To find out about what has been done and can be done to fight corruption in the pharmaceutical sector.

Policy

  • Sub-categories HIV/AIDS, Malaria, Reproductive health, TB
  • Commodities Medicines
  • Latest update 2010
  • Version 2010
  • Developed by WHO/OMS
  • When to use To find out about what has been done and can be done to fight corruption in the pharmaceutical sector.
  • Languages English
  • Level of use Central
  • Form PDF document, 1.8 MB
  • Amount of training / TA required None
  • Inputs & outputs None
  • Cost Free
  • Advantages The document describes concrete achievements based on country experiences. In addition it is short, concise and easy to read.
  • Limitations None
  • Availability http://www.who.int/healthsystems/topics/financing/healthreport/25GGM.pdf
  • Remarks Contact: Dr. Guitelle Baghdadi-Sabeti (WHO)
  • Contact baghdadig@who.int
  • Submission date 2010-12-08 19:20:08